#Baxter Sigma Spectrum

[orbitbrain]

Rapid7 Flags Multiple Flaws in Sigma Spectrum Infusion Pumps

Rapid7 Flags Multiple Flaws in Sigma Spectrum Infusion Pumps

Home › Endpoint Security Rapid7 Flags Multiple Flaws in Sigma Spectrum Infusion Pumps By Ionut Arghire on September 08, 2022 Tweet Security researchers at Rapid7 are warning about multiple secuirty vulnerabilities impacting Baxter’s Sigma Spectrum infusion pumps, including issues that could lead to the leakage of credential. In an advisory published Thursday, Rapid7 called attention to five…

[cyber-sec]

New Vulnerabilities Reported in Baxter's Internet-Connected Infusion Pumps

Source: https://thehackernews.com/2022/09/new-vulnerabilities-reported-in-baxters.html

More info: https://www.rapid7.com/blog/post/2022/09/08/baxter-sigma-spectrum-infusion-pumps-multiple-vulnerabilities-fixed/

[jerbaniumgreen-blog]

Polypharmacy, A True Threat To Our Health

It is common practice in Medicine to put patients on combinations of drugs. The vast majority of these combinations of drugs (especially where 3 or more drugs are involved) have never been studied at all, let alone in double-blind trials ( with the exception of Oncology/AIDS treatment, where the toxicity of the drugs demands study); yet it is frequent practice to prescribe these multiple-drug combinations.

It is well accepted in Pharmacology that it is scientifically impossible to accurately predict the side effects or clinical effects of a combination of drugs without studying that particular combination of drugs in test subjects. Knowledge of the pharmacologic profiles of the individual drugs in question does not in any way assure accurate prediction of the side effects of combinations of those drugs, especially when they have different mechanisms of action, which is very common because polypharmacy is most often prescribed to patients with "multiple illnesses". More than 100,000 patients in this country die from identified adverse drug reactions (perhaps the 4th to 6th leading cause of death in the U.S.)3 The number who die as a consequence of polypharmacy is, to my knowledge, unknown.

The argument that the prescribing of drugs is the "Art" of Medicine is not valid in defending polypharmacy, because drugs are developed (indications, dose and administration, etc.) and approved through a "scientific" process (double-blind, placebo-controlled studies). The fact that the medicines are often prescribed for "different conditions" is irrelevant (especially to the patient's physiology). The idea that " we are doing the best we can ", a frequent defense of Polypharmacy, does not in any way uphold a scientific argument in favor of it. (We are, indeed, trying the best we can, with tools which do not improve at the rate we would wish!) The fact that "there is a limit to how much research can be done" in no way makes the research unnecessary in order to predict the side effects of specific combinations of drugs.

It has been said in the past that <30% of medical practice was backed by controlled studies ¹ • ². Has this changed? How do we know? Are we looking closely enough at our way of practicing Medicine? Can the use of unstudied polypharmacy really be considered evidence-based, "scientific" Medicine? Can the Pathology community help initiate meaningful debate regarding this subject at a level that will produce more widespread awareness?

To learn more about Mindray A5 visit somatechnology.com

[demianblog]

Rapid7 analiza las vulnerabilidades de la bomba de infusión SIGMA Spectrum y la batería Wi-Fi

Rapid7 analiza las vulnerabilidades de la bomba de infusión SIGMA Spectrum y la batería Wi-Fi

El 20 de abril de 2022, rápido7 descubrió vulnerabilidades en dos dispositivos médicos habilitados para TCP/IP producidos por Baxter Healthcare. Las fallas, cuatro en total, afectaron la bomba de infusión SIGMA Spectrum y la batería SIGMA WiFi de la compañía. Casi cinco meses después de que Rapid7 informara por primera vez los problemas a Baxter, las empresas ahora revelan que trabajaron juntas…

[stellarakash23]

Acute Lymphocytic Leukemia Therapeutics Market  Share, Growth, Industry Segmentation, Analysis and Forecast 2027

Acute Lymphocytic Leukemia Therapeutics Market:  size was valued at US$ 2.92 Billion in 2020 and the Acute Lymphocytic Leukemia Therapeutics revenue is expected to grow at 4.19% through 2021 to 2027, reaching nearly US$ 3.89 Billion.

Acute Lymphocytic Leukemia Therapeutics Market Outlook:

Stellar Market Research gives a high-level overview of the Acute Lymphocytic Leukemia Therapeutics market, the most up-to-date market snapshots, and an in-depth understanding of its characteristics. The report provides a market overview, emphasizes common issues, & customizes the data as needed. This analysis will assist you in determining how to approach the market & comprehending the current state of the sector. The outcomes of these surveys are rationally mentioned in this report, and this research strategy has been used to research the Acute Lymphocytic Leukemia Therapeutics Market internationally. Other elements, including supply & demand, distribution networks, consumption, import/export, and capacity, all play a role in providing a competitive advantage to business stakeholders, owners, & field employees. The most crucial information is presented in simple charts, tables, and graphs to incorporate into your business presentation.

Acute Lymphocytic Leukemia Therapeutics Market Scope:

Acute Lymphocytic Leukemia Therapeutics Market reports highlight domestic and international competition by conducting an in-depth analysis of key competitors in markets, applications, and geographies. The survey examines the competitive landscape in depth and reflects on the products offered by businesses and micro market investment opportunities available to investors.

The Acute Lymphocytic Leukemia Therapeutics report provides detailed analysis and information on trends, dynamics, and other issues. This poll identifies key trends that have an impact on your business. This highlights the competitive landscape of major companies, market-influencing aspects, and other criteria that can be used to determine whether current marketing plans are on track and how they can be implemented. Aids in the discovery of research-relevant information.

Request For Free Sample: https://www.stellarmr.com/report/req_sample/Acute-Lymphocytic-Leukemia-Therapeutics-Market/281

Key Players Covers:

Erytech Pharma (France) Spectrum Pharmaceuticals, Inc. (United States) Pfizer, Inc. (United States) Sigma-Tau s.p.a. (Italy) Genzyme Corporation (United States) Amgen, Inc. (United States) Bristol-Myers Squibb Company (United States) Erytech Pharma (France) Leadiant Biosciences, Inc. (Italy) Novartis AG (Switzerland) Rare Disease Therapeutics, Inc. (United States) Sanofi (France) Spectrum Pharmaceuticals, Inc (United States) Takeda Pharmaceutical Company Limited. (Japan)

Acute Lymphocytic Leukemia Therapeutics Market Segmentation:

Chemotherapy is projected to be the most popular sort of treatment when it comes to therapy. According to the American Cancer Society, the major treatment for people with acute lymphoblastic leukaemia (ALL) is chemotherapy, which includes three phases: remission, consolidation, and maintenance. Chemotherapy refers to the use of cytotoxic drugs to kill cancer cells.

Amsacrine (NordMedica), cyclophosphamide (Baxter), and cytarabine (Baxter) are some of the drugs utilised in ALL chemotherapy (Pfizer). Global pharmaceutical businesses such as Baxter International and Pfizer provide these drugs. ALL is the most common malignancy in children, adolescents, and young people under the age of 20, according to a 2019 report by the Leukemia & Lymphoma Society, accounting for 19.8% of all cancer diagnoses in this age group.

Acute Lymphocytic Leukemia Therapeutics PESTEL analysis:

Stellar Market Research's studies include a PESTEL analysis to aid in developing your business strategy. The government uses political issues to determine how it can impact the Acute Lymphocytic Leukemia Therapeutics market. Economic factors aid in analyzing financial performance parameters that influence the Acute Lymphocytic Leukemia Therapeutics market. Marketing analysis and strategic planning benefit from social variables. Legal considerations aid our understanding of the Acute Lymphocytic Leukemia Therapeutics market's environmental and ecological consequences.

The Acute Lymphocytic Leukemia Therapeutics Market Report covers recent trends, trade regulation, import/export analysis, production analysis, value chain optimization, market share, the influence of domestic and domestic market players, new sources of revenue, regulatory changes, strategic market growth analysis, market size, Category market growth, application niches and advantages, product approvals, product launches, and geographic expansion. Acute Lymphocytic Leukemia Therapeutics Please contact Stellar Market Research for an analyst letter if you require additional market information. Our team will assist you in making well-informed market judgments that will help you grow your company.

COVID-19 Impact:

The COVID-19 problem is wreaking havoc on all service and manufacturing companies due to substantial declines in demand. The majority of persons working in this field are in jeopardy. As a result, a significant number of enterprises have shut down. Consumer demand for some product is declining, while the economy in general is faltering. The number of workers at grocery shops and food vendors, on the other hand, has increased. The impact of COVID 19 is detailed in this study.

Acute Lymphocytic Leukemia Therapeutics Regional Analysis:

The Acute Lymphocytic Leukemia Therapeutics report covers the five regions, and their country-wise distribution is:

North America

Europe

Asia Pacific

Middle East & Africa

South America

Competitive Landscape:

The North American Coffee research profiles more than fifteen key market participants from various geographies. When studying the market and estimating its size, however, the data took into account all industry leaders, followers, & new entrants, as well as investors. The Acute Lymphocytic Leukemia Therapeutics report focuses on the regional influence on manufacturing costs, supply chains, raw material availability, labour costs, advanced technology availability, and trusted vendors because each region's manufacturing environment is different. The report also suggests a future hotspot in the Asia Pacific area. This report examines the impact of significant countries' manufacturing policies on demand.

Will You Have Any Questions About This Report? Please Contact Us On link: https://www.stellarmr.com/report/Acute-Lymphocytic-Leukemia-Therapeutics-Market/281

Acute Lymphocytic Leukemia Therapeutics Market research report offers:

The Acute Lymphocytic Leukemia Therapeutics market is defined, as well as the examination of several affecting elements such as drivers, restraints, & opportunities.

Several types available for the product’s application have been analyzed. Statistical analysis has been conducted on obtaining the individual share of these segments.

Identification and analysis of micro & macro elements that influence and will influence market growth.

Extensive analysis into the Acute Lymphocytic Leukemia Therapeutics competitive landscape.

Porter's Five Force Analysis & SWOT analysis are used to define, characterize, and analyse the market competition landscape, with a focus on global key manufacturers.

A complete list of major players in the global Acute Lymphocytic Leukemia Therapeutics market.

In the global Acute Lymphocytic Leukemia Therapeutics market, it provides a descriptive study of demand-supply chaining.

Estimation of the market size along with historic and forecasted trend analysis.

Figures, charts, graphs, & illustrations are used to clearly describe the market.

About Us:

S.No.8, H.No. 4-8 Pl.7/4, Kothrud,

Pinnac Memories Fl. No. 3,

Kothrud, Pune,

Pune,

Maharashtra, 411029

sales@stellarmr.com

[jerbaniumgreen-blog]

Medical Equipment In Your Bathroom

Because people grow older, they turn out to be less steady on the feet. It is harder to allow them to take bathing and showers, but it’s also often the matter associated with pride at having the ability to do then when possible. For seniors and anyone who has had current injuries or even surgery, using the bath seat or bath stool is really a safer method to bathe. When mobility is restricted, other accessories could be installed or put into the person’s bathroom in order to limit the actual risks associated with falling. These specifically designed devices can be bought from on the internet homecare healthcare equipment providers. When the individual is uncertain of what kind to purchase or what will be most advantageous, it is better to seek advice from their doctor. They ought to use products specially designed for the restroom, shower or even bathtub. Home healthcare equipment that’s exposed in order to water won’t rust or even deteriorate.

Shower Seat

There are a number of shower chairs available on the market. They permit the user to take a seat comfortably whilst bathing. This is particularly helpful for individuals that depend on walkers, canes as well as crutches to obtain around. Different styles work with different sufferers. For instance, the stool doesn’t have arms as well as fits places a normal shower chair won’t, while seats with arms tend to be more helpful for all those needing additional support getting into and away. The arms could get when it comes to bathing, depending on the person’s dimension and capabilities. A table is longer than the usual stool as well as makes much more room with regard to propping upward feet with regard to cleaning as well as rinsing or even for shaving the actual legs. Shower chairs ought to be equipped along with nonskid tips about the bottom from the legs to avoid movement as well as marring the actual tub or even shower area. Some versions have progressing feet to avoid tipping.

To learn more about Philips Intellivue MP5 and Baxter Sigma Spectrum visit Soma Technology, Inc.

[openhealthcaretechworks]

The Risk-Free Use Of Infusion Tools

Infusion tools are utilized thoroughly in each scientific locations as well as are actually an essential resource for providing perioperative treatment, essential care and pain administration. Problem has actually been lifted regarding the higher likelihood of vital occurrences connected to these devices. The majority of these happenings disclosed to the Medical Instruments Organization (now part of Medicines and also Medical care products Regulatory Agency (MHRA)) is actually attributable to human mistake. The National patient Security Agency has actually consequently started a job in a try to minimize the amount of these errors. Plannings consist of regimentation of gadgets, examination of customer adventure, possible growth of equipment collections and internet-based instruction. Whilst there is actually an overwelming option of tools readily available, they are essentially either syringe chauffeurs or volumetric pumps.

The Key points of Sigma Spectrum

Three treatment categories have actually recently been described for Baxter infusion pump.

Making use of pre-filled syringes and also infusion bags substantially minimizes danger.

infusion pipes should be purged after link to a pump to 'occupy technical slack' and minimize hold-up in onset.

A significant unintentional infusion bolus can easily comply with the release of a line occlusion.

A multidisciplinary team needs to be actually set up in every health center to establish a typical method to procurement, instruction, maintenance and storage of infusion gadgets.

How Infusion-Pumps Have Resulted In Improvements In patient Safety

It happens that a sick person requires an intravenous infusion of medicines in a small loudness as well as at a consistent reduced speed. Formerly the owner needed to keep an eye on the dropper regularly, at times counting the variety of reduces with a stopwatch in his palms. This is actually a factor of the past times.

The infusion-pump is actually a pump for dosed, long-lasting administration of a variety of clinical services intravenously or for the intro of nutrient options to severe clients. A Baxter infusion pump is actually a device that can easily provide drugs in numerous methods: drip, volume, and also bolus. Frequently, infusion-pumps are actually used for intravenous infusion of medicines, however may likewise be actually made use of for epidural, subcutaneous, enteral, and also various other accessibilities.

There are actually now infusion-pumps (perfusion, infusion syringe pumps) that permit you to provide drugs ad services intravenously at a specific speed, and also some designs even permit you to compute the fee of management of the drug depending upon the attention of the remedy, the weight of the dosage as well as the individual got. A mixture pump is convenient for infusing patient.

Features of an Infusion Pump

The Baxter Sigma Spectrum is used in intense care and anaesthesia. High preciseness electronic devices make full safety and security for the patient. Utilizing the plan, it is actually achievable to infuse several medications simultaneously; the pre-set electronic course will definitely activate the device quickly, compute the dose of medicine and also being infusion at a specific rate. Such infusions could be executed at any moment of time according to the criteria specified by the electronic unit.

The conveniences of using an infusion pump compared to a standard drip system is actually that the patient resides in a position beneficial for it, which makes it possible for the tool to be made use of for resting patient and also commonly changing their settings.

The infusion-pump is actually configured so that they respond rapidly and also state along with an audio signal concerning a blockage, obstacle to the flow of the infusion solution and inform you regarding the conclusion of the infusion. The infusion pump has a safe syringe change unit, immediately latches the syringe, as well as identifies it amount, which guarantees a continual option. A mixture pump has environments to figure out the dose of the drug, taking into consideration the body weight of the patient. The infusion-pump operates from a 220V system or autonomously coming from the electric battery for a few hrs, which allows for infusion in any sort of practical area.

[eliteinternet1]

Outfront Medical can help you buy products like a curline 6000 CMS PCA infusion pump for less. We sell and rent a variety of medical equipment for less, including both new and used equipment, allowing you to get the best deals possible on that equipment today.

[marketindustryreports]

IV Equipment Market Upcoming Demand & Growth Analysis Up to 2030

The recent research, IV Equipment market enables stakeholders, field marketing executives and business owners get one step ahead by giving them a better understanding of their immediate competitors for the forecast period, 2019 to 2030. Most importantly, the study empowers product owners to recognize the primary market they are expected to serve. To help companies and individuals operating in the IV Equipment market ensure they have access to commensurate resources in a particular location the research, assess the size that they can realistically target and tap.

Increasing geriatric population coupled with growing number of surgical procedures has been pivotal in dictating the growth of the IV equipment market. Moreover, Increasing patient awareness, rising prevalence of chronic diseases and increasing expenditures on healthcare is anticipated to be the major drive the growth of the global IV equipment market between 2019 and 2030. Christe University, along with Christie Medical Holdings, Inc. entered into collaborative agreement with B Braun Medical in 2017, to improve peripheral IV access success. Collaborations and partnerships of such forms is anticipated to further contribute to the growth of the IV equipment market, by promoting new innovative techniques of administering medications and other substances with greater efficiency through the intravenous routes.

Get Free PDF Sample Copy @ https://www.marketindustryreports.com/pdf/34

Some key points of TOC:

1. Global IV Equipment Market - Analysis & Forecast, By Product

2. Introduction & Definition

3. IV Catheters

4. Infusion Pumps

5. Stopcocks & Check Valves

6. Needleless Connectors

7. Administration Sets

8. Securement Devices

9. Drip Chambers

10. Other IV Equipment

11. COMPANY PROFILES (Business Overview, Products Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*

12. BD

13. B. Braun Melsungen AG

14. Baxter

15. Fresenius SE & Co. KGaA

16. ICU Medical, Inc.

17. Smith Medical (Smiths Group plc.)

18. TERUMO CORPORATION

19. MOOG INC.

20. AngioDynamics

21. Medline Industries, Inc. (*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)

Increasing Geriatric Population

The population of geriatric population across the world has grown rapidly over the past several decades. Moreover, this growth has witnessed an unprecedented rate in recent times. In 2016, it was approximated that the population of individuals aged 65 years or older was 8.5% or 617 million of the entire world population. Furthermore, it is projected that the figure will witness an increment to 17% i.e. 1.6 billion by the end of 2050. Such rapid growth of geriatric population is anticipated to present a remunerative growth opportunity for the global IV equipment market in the coming times. Since, the utilization of IV Equipment products for assisting treatment and facilitating faster recovery among aged population is enormously crucial.

Growing Number of Surgical Procedures

An increasing number of surgeries has been a major contributor to the growing demand for IV equipment worldwide. According to the Centers for Disease Control and Prevention (CDC), in U.S., a total of 51 million inpatient surgical procedures were performed in 2010. It is estimated that the global burden of surgical conditions is a staggering 28-32%. Similarly, growing preference for minimally-invasive cosmetic procedures in anticipated to further propel the growth of the IV equipment market.

Product Recalls to Restrain the Market

Risks factors to the health of patients as a result of medication error have been a major factor contributing to the product recalls in the IV equipment market. Internal errors in infusion pumps in the past have led to wide product recalls by the government bodies. For instance, in October 2017, FDA recalled Baxter SIGMA Spectrum Infusion Pump, citing error messages. Product recalls is anticipated to be a vital aspects restraining the prosperous growth of the IV equipment market.

Rapid Growth of the Asia Pacific Market

Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing geriatric population, continuously growing economy, and increasing burden of chronic diseases and is anticipated to present a lucrative growth scenario for the IV Equipment market in this region. Furthermore, improving healthcare infrastructure, coupled with supportive government healthcare regulations and norms is expected to present an attractive growth prospect for the market in the coming years.

Get Report pdf click here:https://www.marketindustryreports.com/checkout/34

About Us

Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.

Contact Us-

502, Sai Radhe, Kennedy Road,

Behind Hotel Sheraton Grand, Near Pune Station, Pune 411 001 Email: sales@marketindustryreports.com Phone: +1 347 767 5477 ( US ) + 91 8956 767 535 ( IN ) Website: https://www.marketindustryreports.com/ Follow Us- LinkedIn | Twitter | Facebook

[pragya1-blog]

Drug Delivery Systems Market is Anticipated to Reach a Value of US$ 900.0 Bn by 2025

The report offers detailed segmentation of the global drug delivery system market based on delivery system, application, route of administration, and geography. In terms of delivery system, the targeted drug delivery segment is expected to account for a dominant share of the global market during the forecast period. Simplified drug administration protocols, avoidance of first pass metabolism, lower dose required as compared to the conventional drug delivery, and higher therapeutic effect in small doses are some factors propelling the segment. The polymeric drug delivery segment is likely to expand at a considerable growth rate during the forecast period. Polymeric drug delivery systems allow localized drug delivery in large quantity for the treatment of chronic diseases such as cancer (more specifically, solid tumors) with lower toxicity. This is a major factor driving the segment.

Obtain Report Details @

https://www.transparencymarketresearch.com/drug-delivery-systems-market.html

Drug delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect. The global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. Increase in demand for self-administration and home health care devices are likely to fuel expansion of the global drug delivery systems market from 2017 to 2025.

In terms of value, North America was leading contributor to the global drug delivery system market in 2016. North America accounted for a key share of the market due to rise in prevalence of acute and chronic diseases in the U.S. According to WHO report 2016, non-communicable diseases accounted for 23% of total deaths in the U.S. Moreover, availability of advanced technology and facilities in the health care system also drive the drug delivery system market in the U.S. Moreover, rise in research & development spending in emerging markets such as Singapore and Japan is fueling the market in Asia Pacific. Economic growth in countries such as Brazil is increasing health care expenditure through the rise in private health insurance and entry of international drug manufacturers and health care providers in Latin America. Hence, the market in the region is likely to expand at a CAGR of 5.5% from 2017 to 2025.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41543

Continuous innovations in the global drug delivery systems market is creating opportunities for major and local manufacturers to develop wide product portfolio. Additionally, collaborations among major market players for superior technological advancements in drug delivery offerings is likely to drive the global drug delivery systems market during the forecast period. Using nanotechnology, the drug can be targeted to a precise location, which makes drugs more effective and reduce the chances of possible side effects. Major manufacturers operating in the market are involved in continuous research & development activities to expand their already wide product portfolio. For instance, on September 2017, Baxter International Inc. announced the launch of DeviceVue, an asset tracking system for sigma spectrum infusion system whereas, emerging players operating in the market are also focusing on introducing new versions of their existing drug delivery devices. Continuous expansion of drug delivery systems offering in high throughput along with reduced waiting time and improved result specificity are likely to drive the global drug delivery systems during the forecast period. However, high cost associated with treatment and increase in drug recalls are likely to restrain the global drug delivery systems market during the forecast period.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41543

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research State Tower, 90 State Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: www.transparencymarketresearch.com

[jerbaniumgreen-blog]

Adults with newly diagnosed diabetes at risk of liver disease

Adults with newly diagnosed diabetes are at higher long-term risk of serious liver disease, including cirrhosis and liver failure, according to a recent study.

The negative impact of diabetes on the eye, kidney and blood vessels is well-known, but little is known about its effect on the liver.

The Canadian research team found an incidence rate of 8 per 10 000 person-years for serious liver disease in people with newly diagnosed diabetes compared to a rate of 4 per 10 000 person years among non-diabetic controls. They note that persons with diabetes and concomitant obesity or hypertension had the highest risk of liver disease.

“We conclude that the presence of overt diabetes reflects more severe insulin resistance, a greater fatty load in the liver and potentially worse hepatic inflammation and injury,” says Dr. Gillian Booth of St. Michael’s Hospital.

“Those who have diabetes may not just have higher blood sugars, but greater long-term insulin resistance and fatty load to the liver, which ultimately impacts on the integrity of the liver’s cells.”

A previous study by the US Department of Veterans Affairs found that the incidence of serious liver disease was two times higher in people with diabetes, although the study sample comprised older men in hospital.

The authors suggest that the effects of weight loss and glycemic and lipid control should be better understood before instituting annual screening for liver disease.

For more info about Medical equipment and Zimmer ATS 3000 visit SomaTechnologyInc